How can AI help personalize #prostatecancer care?
Hear from Dr. Laura Chang on the PCUK Vanguard Study, how the #ArteraAI Prostate Test works, and Ian’s story.
With @ProstateUK + partners @UniofOxford @BristolUni @UofGlasgow
Real-world validation is key for AI in oncology.
This study highlights multimodal and image-only digital pathology biomarkers validated using multi-institutional data, an important step toward clinical adoption.
Learn more: buff.ly/n4nHxqy
#ProstateCancer #ArteraAI
Who’s most at risk for prostate cancer, and how is treatment evolving?
This episode breaks down risk factors, screening, and how care is becoming more personalized.
Listen here: buff.ly/WikqXR0
#ProstateCancer #ArteraAI #PrecisionMedicine
Looking to learn more about the #ArteraAI Prostate Test (Post-RP)? Join this webinar on 4/13 to get all the details about how the test works, how to incorporate it into practice, how to interpret the test report, and how it can help personalize treatment plans. Register now: buff.ly/lkQl2Q0
AI in oncology can’t just predict, it needs to explain.
New research from #GU26 explores the biologic pathways behind multimodal digital pathology AI in metastatic #prostatecancer, helping open the “black box.”
Read more: buff.ly/wyh1uXX
How can one test support decisions across the #prostatecancer journey?
Hear how clinicians are using the #ArteraAI Prostate Test to guide care, from active surveillance to treatment decisions and recurrence.
Watch the replay: heyor.ca/w8m0LI
#PrecisionMedicine
How is AI transforming cancer treatment?
Listen to the conversation on how AI-powered tools are helping personalize care for patients: heyor.ca/uP2kp0
#AIinHealthcare #ProstateCancer #PrecisionMedicine #ArteraAI
